Discovery of an RNF126-Dependent Polθ Degrader Exhibiting In Vivo Activity in an HR-Deficient Tumor Model
Journal of Medicinal Chemistry · 18.11.2026
DOI: 10.1021/acs.jmedchem.6c02430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.11.2026. Verfasst von Luyu Ma und 7 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
DNA polymerase theta (Polθ), a multidomain DNA repair enzyme, has emerged as a promising synthetic-lethal target in homologous recombination (HR)-deficient tumors, yet current inhibitors directed at either its helicase or polymerase domain may not fully suppress the functions of the intact protein. Here, we report PR-6, a RNF126-dependent Polθ degrader identified through comparative degrader screening and structural optimization. In BRCA1-deficient MDA-MB-436 cells, PR-6 induced, concentration- and time-dependent Polθ degradation via an RNF126- and ubiquitin-proteasome-dependent mechanism. Compared with the Polθ helicase inhibitor AB25583 under the tested cellular conditions, PR-6 exhibited greater antiproliferative activity and induced more pronounced DNA damage and apoptosis. Moreover, PR-6 synergized with Olaparib in vitro and markedly potentiated its antitumor efficacy in an MDA-MB-436 xenograft model without overt toxicity. These findings support PR-6 as the first degrader probe for interrogating Polθ biology and provide proof of concept for Polθ degradation as a complementary strategy in HR-deficient tumors.
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Ma, L., Luo, M., Liu, X., Ge, X., Zhang, Z., Xiao, M., Xiang, H., & Luo, G. (2026). Discovery of an RNF126-Dependent Polθ Degrader Exhibiting In Vivo Activity in an HR-Deficient Tumor Model. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02430
Vancouver
Ma L, Luo M, Liu X, Ge X, Zhang Z, Xiao M, et al. Discovery of an RNF126-Dependent Polθ Degrader Exhibiting In Vivo Activity in an HR-Deficient Tumor Model. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c02430
BibTeX
@article{Ma2026,
author = {Ma, Luyu and Luo, Mingjin and Liu, Xinyan and Ge, Xiaofan and Zhang, Zhonglin and Xiao, Maoxu and Xiang, Hua and Luo, Guoshun},
title = {Discovery of an RNF126-Dependent Polθ Degrader Exhibiting In Vivo Activity in an HR-Deficient Tumor Model},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02430}
}
EUVIMED